Product Description
The global cerebrospinal fluid management market was valued at approximately $327 million in 2025. This is expected to increase over the forecast period at a CAGR of 2.8% to reach approximately $397 million by 2032.
The full report suite on the global market cerebrospinal fluid management market (CSF) includes the CSF shunt and CSF drainage shunt segments.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Cerebrospinal Fluid Management Market Trends

Emerging shunt technologies and advancements in intracranial pressure monitoring are improving diagnosis rates of hydrocephalus and making CSF management devices more attractive to physicians. In addition, innovations such as antimicrobial-coated catheters are expected to enhance clinical outcomes while supporting higher ASPs, contributing to market growth. Healthcare providers often operate under tight budgets and are hesitant to adopt higher-cost, innovative CSF devices when existing shunt systems remain clinically sufficient. This discourages manufacturers from investing in new technologies, creating a cycle that slows product innovation and limits overall market growth.
Global Cerebrospinal Fluid Management Market Share Insights

- Medtronic was the leader in the cerebrospinal fluid management market in 2025 due to its strong position in the shunt segment and the drainage segment. The company offers the adjustable PS Medical® Strata® valves, which enables non-invasive adjustment by physicians with hand-held tools. These valves also have over-drainage protection and can be attached to a ventricular or distal catheter. These valves are MRI compatible.
- Integra LifeSciences held the second-leading position in the CSF market by offering a number of products, including CODMAN® shunt systems, the BACTISEAL® and HAKIM® BACTISEAL® systems.
- B. Braun was the third-leading competitor in the cerebrospinal fluid management market in 2025. The company competes in the market with its MIETHKE proGAV 2.0®, the proGAV® and the MIETHKE GAV®, which are all adjustable gravitational shunt valves.
Global Cerebrospinal Fluid Management Market Segmentation Summary
- Cerebrospinal Fluid (CSF) Management Market – Further Segmented Into:
- Device Type: CSF Shunt, and CSF External Drainage System.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.